CRVS Operating Expenses

Corvus Pharmaceuticals Inc · Operating Expenses

CRVS logo

CRVS Operating Expenses

Latest reported$56.94M
CRVS TTM Operating Expenses ($13.77M → $56.94M)
High-resolution chart · PNG

CRVS operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Corvus Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
56,937,000
47,900,000
42,945,000
38,859,000
35,542,000
31,217,000
27,548,000
25,094,000
23,399,000
23,086,000
23,407,000
23,422,000
30,335,000
31,726,000
32,565,000
33,709,000
30,283,000
34,560,000
38,630,000
41,699,000
42,497,000
41,974,000
43,760,000
45,321,000
46,989,000
49,818,000
48,854,000
48,585,000
48,221,000
46,883,000
49,222,000
50,240,000
52,035,000
54,951,000
56,524,000
55,584,000
53,116,000
46,767,000
36,976,000
31,831,000
24,475,000
17,982,000
13,770,000
7,819,636
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.